Navigation Links
Egon Zehnder International Names Todd Hutchings to Lead Life Sciences Practice Group
Date:12/6/2010

LOS ANGELES, Dec. 6, 2010 /PRNewswire/ -- Todd Hutchings has assumed leadership of Egon Zehnder International's North American Life Sciences Practice Group.  Peter Levin, who led the practice, will continue at the firm in an active client-facing role recruiting CEOs and C-Level executives.

In his new role, Mr. Hutchings will be responsible for deepening core client relationships, working with boards and providing the full array of functional leadership capabilities to Life Science companies. Since joining EZI in 2005, Mr. Hutchings has been a critical member of the practice, working across a wide variety of functions and life sciences segments and developing a specialty in diagnostics and biotech. 

Prior to joining EZI, he served as Director, Business Planning for Roche Diagnostics and as a consultant for McKinsey & Company and The Monitor Group.

"Todd Hutchings has played a vital role in the growth of the LSPG. We are looking forward to his experience and insights in his new leadership position," said Karena Strella, Managing Partner of the firm's California Practice.

Mr. Hutchings earned his Honors Bachelor of Commerce degree from McMaster University and his MBA from the Richard Ivey School of Business. He resides in Los Angeles.

About Egon Zehnder International

Egon Zehnder International is one of the largest privately-held executive search firms in the world with nearly 400 consultants operating from 63 wholly owned offices in 37 countries.  The firm specializes in senior-level executive search, board consulting and director search, management appraisals, and talent management.  Egon Zehnder International's clients range in size from the world's largest corporations to emerging growth companies to government and regulatory bodies and major educational and cultural organizations. Egon Zehnder International has sector specialists organized into global practices. These include Industrial, Financial Services, Consumer, Life Sciences, Technology & Communications, Services, Private Capital and Sovereign Wealth Funds. For more information visit  www.egonzehnder.com.


'/>"/>
SOURCE Egon Zehnder International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
2. Yongye Biotechnology International Retains CCG Investor Relations
3. Huifeng Bio-Pharmaceutical (HFGB) Announces USD $1.1 Million Supply Agreement with DNP International Co. Inc.
4. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
5. Yongye Biotechnology International Announces Second Quarter Results
6. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
7. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
8. PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference
9. Mindray Medical International Announces Second Quarter 2008 Results
10. Singapore to hold international pow-wow
11. Sangui BioTech International, Inc. Files Remaining Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... 2017  Spherix Incorporated (Nasdaq: SPEX ) ... of technology and monetization of intellectual property, today provided ... Anthony Hayes , Chief Executive Officer of ... to communicate with shareholders about the status of existing ... on other patent assets that fit with our current ...
(Date:1/23/2017)... ... January 23, 2017 , ... Calvert Labs, Inc. announced ... and Senior Director, Safety Pharmacology. Dr. Thomas earned his M.Sc. and Ph.D. ... career as an academic and industry preclinical drug developer spans more than three ...
(Date:1/21/2017)... ... January 20, 2017 , ... ... resource to the healthcare industry ( http://www.gandlscientific.com ), has announced the opening of ... of clinical and scientific consultants and contractors. This is the latest step in ...
(Date:1/21/2017)... -- Bioptix, Inc. (Nasdaq: BIOP ... 14, 2017 the Board of Directors of the Company ... certain employees associated with the September 2016 acquisition of ... on January 16, 2017 and terminations are expected to ... severance benefits in certain circumstances of up to one ...
Breaking Biology Technology:
(Date:12/15/2016)... and BADEN-BADEN, Germany , December 15, ... global financial services provider, today announced an agreement with NuData ... biometrics, to join forces. The partnership will enable clients to ... in compliance with local data protection regulation. ... In order to provide ...
(Date:12/15/2016)... Dec. 14, 2016 "Increase in mobile transactions ... The mobile biometrics market is expected to grow from ... by 2022, at a CAGR of 29.3% between 2016 ... as the growing demand for smart devices, government initiatives, ... "Software component is expected to grow at a ...
(Date:12/7/2016)... Israel , December 7, 2016 BioCatch ... the expansion of its patent portfolio, which grew to over 40 granted ... , , ... its recently filed patent entitled " System, Device, and Method ... technology that enables device makers to forego costly hardware components needed to ...
Breaking Biology News(10 mins):